🧠Neurosurgeon-Scientist @NeurosurgeryUSC | Editor, Neurosurgical Focus | Vice Chair, Education | Director @USCBTC Advancing #BrainTumor & #Pituitary care
Los Angeles, CA
Joined November 2013
- Tweets1.2K
- Following1.2K
- Followers4.7K
- Likes22.7K
Gabriel Zada, MD, MS retweeted
#OnlineFirst: Quantitative MRI to assess baseline shunt flow in patients with hydrocephalus: a noninvasive tool to aid clinical decision-making.
ow.ly/42Bx5100HOv.
#JNSPG #Hydrocephalus #VPShunt
Gabriel Zada, MD, MS retweeted
Just over two weeks left until our L.A. #BT5K! Please join us on Saturday, 11/7 at Crescent Bay Park in Santa Monica: give.abta.org/event/2026-los…
Registration opens at 8 AM, the morning program starts at 9 AM, and the 5K will begin at 9:30 AM.
Gabriel Zada, MD, MS retweeted
Don't miss out on the Section Sessions at the upcoming #CNS! Mark your calendars today!
Gabriel Zada, MD, MS retweeted
Neurosurgical Focus Editor's Choice • October 2026. FIG. 2. Case 1. Pre-, intra-, and postoperative images obtained in a 58-year-old female with metastatic NSCLC, previous SBRT to an L4 vertebral body metastasis, and acute right L4 radiculopathy.
thejns.org/doi/10.3171/2026.…
Gabriel Zada, MD, MS retweeted
Join the AANS/CNS Joint Section on Tumors at #CNS2026 in Washington, D.C. for two days of connection, mentorship, and a little friendly competition.
#Neurosurgery #NeuroOncology #CNS2026
Gabriel Zada, MD, MS retweeted
Interested in a career in neurosurgical oncology?
Join the AANS/CNS Joint Section on Tumors Resident Subcommittee at #CNS2026 for our Fellowship Meet & Greet.
📅 Nov 1 | 8:15–10:45 PM
đź“Ť Flight Club DC
🎟️ FREE registration
Register: rebrand.ly/TSCNS2026
Gabriel Zada, MD, MS retweeted
We're proud to see Dr. Ruzevick and the multidisciplinary team recognized in this inspiring story of Arturo's return to marching band following brain tumor treatment.
Congratulations to Arturo on this remarkable milestone!
Read more: nbcrightnow.com/news/highlan…
Gabriel Zada, MD, MS retweeted
Excited and honored to join the AANS/CNS Tumor Section Resident Subcommittee for 2026–2027! Looking forward to advancing research, education, mentorship, and advocacy in neurosurgical oncology. Grateful for this opportunity and my mentors’ support. @NSTumorSection
Gabriel Zada, MD, MS retweeted
ow.ly/UnQt50ZV8Ob
Dr. Gabriel Zada, Editor Neurosurgical Focus, gives an overview of the October 2026 issue.
The issue is free to access at ow.ly/ATpy50ZV8Oc.
Gabriel Zada, MD, MS retweeted
Join the AANS/CNS Joint Section on Tumors at #CNS2026 in Washington, D.C. for two days of connection, mentorship, and a little friendly competition.
#Neurosurgery #NeuroOncology #CNS2026
Gabriel Zada, MD, MS retweeted
Interested in a career in neurosurgical oncology?
Join the AANS/CNS Joint Section on Tumors Resident Subcommittee at #CNS2026 for our Fellowship Meet & Greet.
📅 Nov 1 | 8:15–10:45 PM
đź“Ť Flight Club DC
🎟️ FREE registration
Register: rebrand.ly/TSCNS2026
Gabriel Zada, MD, MS retweeted
🧠Can we predict residual tumor before meningioma surgery?
Our multicenter study shows that clinical and anatomical factors remain the strongest predictors, while radiomics may provide complementary value.
DOI: 10.3171/2026.6.FOCUS26266
#Meningioma #Radiomics #MachineLearning
Some scenes from an unforgettable 2026 American Academy of Neurogical Surgery in Ojai, CA with colleagues and friends. I am beyond grateful.
@NeurosurgeryUSC @uscbtc #neurosurgery #surgery #medicine
@DrAlexKhalessi @BobCarterMD
Gabriel Zada, MD, MS retweeted
This article in Neurosurgical Focus provides clinical perspectives for the practicing #neurosurgeon on integrative multiomic analyses of aggressive #meningiomas.
Read here: bit.ly/4yAAepR
Gabriel Zada, MD, MS retweeted
Huge congratulations to my partner Brad Elder, M.D., (@NeurosurgeryOSU) on his election to the American Academy of Neurological Surgery.
Membership in the Academy is one of the highest honors in our field. It recognizes surgeons who have made a lasting impact through their clinical excellence, scholarship, and leadership. Brad embodies all of that, and he's earned every bit of this.
Incredibly proud to call him a colleague and friend here at Ohio State University. Well deserved.
#Neurosurgery #OhioStateUniversity #AAcNS #Academy
@OhioStateMed @OSUWexMed @OSUGeneTherapy
Gabriel Zada, MD, MS retweeted
New pub: thejns.org/focus/view/journa…
Taking endoscopic spine surgery planning to 'the next level'. Congratulations to the team!
Gabriel Zada, MD, MS retweeted
Here's our new paper on how specific histopathologic features in #meningioma predict adverse molecular profiles.
Two take-home points:
1. Some atypical meningioma histopathologic features are more important than others;
2. Molecular testing may actually have greatest added value in WHO grade 1 tumors, not grades 2-3.
academic.oup.com/neuro-oncol…
Gabriel Zada, MD, MS retweeted
Honored to serve as a course director for the 2026 RUNN Course in Pacific Grove, supporting the development of neurosurgical residents through research education, mentorship, and collaboration in the neurosciences. @SNS_Neurosurg #RUNN2026
Gabriel Zada, MD, MS retweeted
Read the article “Anatomical location reflects distinct #cytogenetic signatures in #intracranial #meningiomas” in this month’s edition of Neurosurgical Focus:
thejns.org/focus/view/journa…
Gabriel Zada, MD, MS retweeted
Radiotherapy after surgery halves risk of recurrence in a type of brain tumour that can often grow back, trial shows.
Find out more in The Lancet: spkl.io/60137TUFS #EANO2026
ALT Kaplan\u2013Meier estimates of disease-free survival by treatment group in the intention-to-treat population. Median follow-up was 64 months (IQR 50\u201375). HR=hazard ratio. Copyright: 2026 The Author(s). Published by Elsevier Ltd. CC BY 4.0.